Sinsin Pharmaceutical Co. Ltd Working Capital to Net Assets Ratio
Sinsin Pharmaceutical Co. Ltd working capital to net assets ratio. Sinsin Pharmaceutical Co. Ltd (002800) has a Working Capital to Net Assets ratio of -4.6% as of September 2025. Working capital of ₩-3.28 Billion (current assets of ₩59.01 Billion minus current liabilities of ₩62.29 Billion) is measured against net assets of ₩71.01 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. Check 002800 intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Sinsin Pharmaceutical Co. Ltd (2016–2024)
Working capital to net assets ratio of Sinsin Pharmaceutical Co. Ltd from 2016 to 2024. This chart shows how Sinsin Pharmaceutical Co. Ltd's Working Capital to Net Assets ratio has evolved across 9 annual periods from 2016 to 2024. As of September 2025, the ratio stands at -4.6%, reflecting working capital of ₩-3.28 Billion against net assets of ₩71.01 Billion KRW. See 002800 cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
Sinsin Pharmaceutical Co. Ltd Working Capital to Net Assets Ratio by Year (2016–2024)
Sinsin Pharmaceutical Co. Ltd working capital to net assets ratio by year from 2016 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for Sinsin Pharmaceutical Co. Ltd from 2016 to 2024, covering 9 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see 002800 total asset value.
| Year | WC/NA Ratio | Working Capital (KRW) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | -11.5% | ₩-7.61 Billion | ₩65.87 Billion | ₩51.49 Billion | ₩59.10 Billion | ▼ -4.1 pp |
| 2023 | -7.4% | ₩-4.61 Billion | ₩62.09 Billion | ₩47.11 Billion | ₩51.72 Billion | ▼ -12.0 pp |
| 2022 | 4.6% | ₩2.72 Billion | ₩59.70 Billion | ₩45.05 Billion | ₩42.33 Billion | ▼ -0.1 pp |
| 2021 | 4.6% | ₩2.55 Billion | ₩54.93 Billion | ₩36.47 Billion | ₩33.92 Billion | ▼ -4.8 pp |
| 2020 | 9.4% | ₩5.30 Billion | ₩56.20 Billion | ₩39.68 Billion | ₩34.38 Billion | ▼ -8.0 pp |
| 2019 | 17.4% | ₩9.81 Billion | ₩56.36 Billion | ₩44.59 Billion | ₩34.78 Billion | ▼ -8.4 pp |
| 2018 | 25.8% | ₩14.08 Billion | ₩54.54 Billion | ₩44.81 Billion | ₩30.72 Billion | ▼ -19.5 pp |
| 2017 | 45.3% | ₩23.62 Billion | ₩52.12 Billion | ₩41.46 Billion | ₩17.84 Billion | ▼ -3.4 pp |
| 2016 | 48.7% | ₩16.77 Billion | ₩34.43 Billion | ₩34.53 Billion | ₩17.76 Billion | — |